Drug Profile
Neurturin
Latest Information Update: 28 Nov 2006
Price :
$50
*
At a glance
- Originator Washington University
- Developer Genentech
- Class Antiparkinsonians; Nerve growth factors; Neuroprotectants
- Mechanism of Action Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; Parkinson's disease